Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Nuformix (NFX) Share Price

Price 0.0875p on 02-07-2025 at 18:50:08
Change -0.005p -5.41%
Buy 0.09p
Sell 0.085p
Buy / Sell NFX Shares
Last Trade: Sell 4,286,330.00 at 0.0855p
Day's Volume: 12,395,973
Last Close: 0.0875p
Open: 0.0925p
ISIN: GB00BYW79Y38
Day's Range 0.0875p - 0.0925p
52wk Range: 0.04p - 0.30p
Market Capitalisation: £1m
VWAP: 0.086649p
Shares in Issue: 1,696m

Nuformix (NFX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 4,286,330 0.0855p Ordinary
16:12:06 - 02-Jul-25
Sell* 51,326 0.085p Ordinary
14:30:47 - 02-Jul-25
Buy* 177 0.09p Ordinary
12:37:43 - 02-Jul-25
Buy* 100,000 0.08975p Ordinary
09:58:56 - 02-Jul-25
Sell* 75,887 0.0851p Ordinary
09:51:10 - 02-Jul-25
Sell* 6,249,305 0.0872p Ordinary
09:01:10 - 02-Jul-25
Buy* 136 0.095p Ordinary
08:37:37 - 02-Jul-25
Sell* 1,587,500 0.0875p Ordinary
08:00:45 - 02-Jul-25
Sell* 312,500 0.0872p Ordinary
15:33:17 - 01-Jul-25
Sell* 85,116 0.0872p Ordinary
15:26:03 - 01-Jul-25
See more Nuformix trades

Nuformix (NFX) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Jul 2025 (Wed) 0.0925 0.0925 0.0875 0.0875 12,395,973
1st Jul 2025 (Tue) 0.0925 0.0925 0.09 0.0925 4,731,301
30th Jun 2025 (Mon) 0.095 0.095 0.0925 0.0925 33,458,408
27th Jun 2025 (Fri) 0.085 0.1075 0.085 0.095 176,829,927
26th Jun 2025 (Thu) 0.0875 0.0875 0.085 0.085 10,713,044
25th Jun 2025 (Wed) 0.0875 0.0875 0.0875 0.0875 11,463,248
24th Jun 2025 (Tue) 0.095 0.095 0.0875 0.0875 27,667,351
23rd Jun 2025 (Mon) 0.0975 0.0975 0.095 0.095 15,317,127
20th Jun 2025 (Fri) 0.0975 0.0975 0.0975 0.0975 2,660,772
19th Jun 2025 (Thu) 0.10 0.10 0.0975 0.0975 12,357,871
18th Jun 2025 (Wed) 0.10 0.10 0.0975 0.0975 35,843,674
17th Jun 2025 (Tue) 0.1025 0.1025 0.0975 0.10 32,888,613
16th Jun 2025 (Mon) 0.1025 0.1025 0.1025 0.1025 16,830,936
13th Jun 2025 (Fri) 0.1025 0.1025 0.1025 0.1025 5,282,127
12th Jun 2025 (Thu) 0.1025 0.1025 0.1025 0.1025 14,696,035
11th Jun 2025 (Wed) 0.105 0.105 0.1025 0.1025 21,623,383
10th Jun 2025 (Tue) 0.105 0.105 0.105 0.105 7,919,736
9th Jun 2025 (Mon) 0.105 0.105 0.105 0.105 9,717,759
6th Jun 2025 (Fri) 0.1025 0.105 0.1025 0.105 12,812,969
5th Jun 2025 (Thu) 0.11 0.11 0.1025 0.1025 62,061,202
4th Jun 2025 (Wed) 0.1025 0.11 0.1025 0.11 74,433,788
3rd Jun 2025 (Tue) 0.11 0.11 0.1025 0.1025 21,758,747
See more Nuformix price history

Nuformix (NFX) Regulatory News

Date Source Headline
30th May 2025 2:24 pm RNS Total Voting Rights
29th May 2025 7:00 am RNS Confirmation of European ODD for NXP002
23rd May 2025 1:08 pm RNS Publication of a Prospectus
22nd May 2025 7:00 am RNS £210,000 Placing
19th May 2025 7:00 am RNS-R Attendance at American Thoracic Society Congress
2nd May 2025 7:00 am RNS Half-year Report
30th Apr 2025 7:00 am RNS Confirmation of European Orphan Drug Designation
29th Apr 2025 7:00 am RNS Change of Registered Office and Company Secretary
14th Apr 2025 7:00 am RNS Exercise of Warrants
9th Apr 2025 7:00 am RNS NXP002 Update
See more Nuformix regulatory news

Nuformix (NFX) Share News

Nuformix shares fall despite EU orphan drug status for lead treatment

29th May 2025 18:21

(Alliance News) - Nuformix PLC on Thursday said its lead programme, NXP002, has been granted orphan drug designation by the European Medicines Agency for the treatment of idiopathic pulmonary fibrosis. Read More

Nuformix interim loss widens as focused on advancing assets

2nd May 2025 12:19

(Alliance News) - Nuformix PLC on Friday said it has continued to "advance and exploit" assets in its portfolio, two days after noting a positive opinion from an EU committee for NXP002. Read More

Nuformix finds positive data for NXP002 in lung fibrosis study

9th Apr 2025 16:29

(Alliance News) - Nuformix PLC on Wednesday said fresh analysis of lung tissue from patients with idiopathic pulmonary fibrosis and autoimmune-related interstitial lung disease showed "positive" results for its lead asset NXP002, supporting its potential in treating a wider range of fibrotic conditions. Read More

UK shareholder meetings calendar - next 7 days

13th Mar 2025 14:41

Read More

EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix

29th Jan 2025 15:48

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesday and not separately reported by Alliance News: Read More

See more Nuformix news
FTSE 100 Latest
Value8,774.69
Change-10.64

Login to your account

Forgot Password?

Not Registered